|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139,000.00 KRW | +1.68% |
|
+11.38% | +31.50% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-14 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 5,495B 3.57B 3.12B 2.86B 2.67B 5.06B 339B 5.14B 34.45B 13.35B 167B 13.39B 13.1B 574B | P/E 2026 * |
11.5x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.03B 2.62M 2.29M 2.1M 1.96M 3.71M 249M 3.77M 25.27M 9.79M 122M 9.82M 9.61M 421M | EV / Sales 2026 * |
1.09x | EV / Sales 2027 * | 0.95x |
| Free-Float |
56.16% | Yield 2026 * |
2.84% | Yield 2027 * | 3% |
| 1 day | +1.68% | ||
| 1 week | +11.38% | ||
| Current month | +5.38% | ||
| 1 month | +8.26% | ||
| 3 months | +6.92% | ||
| 6 months | +34.82% | ||
| Current year | +31.50% |
| 1 week | 126,200 |  | 145,300 |
| 1 month | 120,300 | | 145,300 |
| Current year | 102,000 | | 150,100 |
| 1 year | 99,000 | | 150,100 |
| 3 years | 81,800 | | 150,100 |
| 5 years | 80,200 | | 150,100 |
| 10 years | 75,700 | | 164,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seung-Joon Lee
CEO | Chief Executive Officer | 66 | 2021-12-31 |
Cheol-Gon Tam
PRN | Corporate Officer/Principal | 71 | 1980-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
In-Cheol Heo
BRD | Director/Board Member | 66 | 2014-06-30 |
Wook Lee
BRD | Director/Board Member | 67 | 2020-02-29 |
Seung-Joon Lee
CHM | Chairman | 66 | 1993-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-01-07 | Others | 17 | 0.0000% | |||
| 24-05-19 | Buy | Company | 10,000,000 | 25.2933% | ||
| 24-05-19 | Others | 861 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +11.38% | +17.30% | +15.83% | 3.57B | |
| -0.77% | +0.59% | +5.26% | -22.31% | 271B | |
| +2.63% | -0.47% | -12.44% | -16.49% | 78.19B | |
| -0.92% | +1.58% | +6.14% | +29.89% | 54.19B | |
| +0.23% | +0.33% | +37.37% | +1.63% | 37.01B | |
| +2.07% | +7.80% | +57.97% | +113.80% | 35.89B | |
| +1.94% | +3.09% | +2.86% | -27.06% | 36.95B | |
| +1.44% | +8.10% | -6.25% | -28.54% | 30.08B | |
| +0.83% | +5.11% | +22.08% | +28.86% | 29.29B | |
| +1.50% | -4.56% | +30.80% | +12.84% | 20.66B | |
| Average | +0.81% | +2.44% | +16.11% | +10.85% | 59.65B | |
| Weighted average by Cap. | +0.01% | +1.28% | +9.24% | -3.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3,700B 2.4B 2.1B 1.93B 1.8B 3.41B 229B 3.46B 23.2B 8.99B 112B 9.02B 8.82B 386B | 3,917B 2.54B 2.22B 2.04B 1.9B 3.61B 242B 3.67B 24.56B 9.52B 119B 9.55B 9.34B 409B |
| Net income | 479B 311M 272M 249M 233M 441M 29.59B 448M 3B 1.16B 14.51B 1.17B 1.14B 50.01B | 522B 339M 296M 272M 254M 481M 32.27B 489M 3.27B 1.27B 15.83B 1.27B 1.25B 54.54B |
| Net Debt | -1,464B -950M -830M -762M -711M -1.35B -90.45B -1.37B -9.18B -3.56B -44.37B -3.57B -3.49B -153B | -1,757B -1.14B -996M -915M -853M -1.62B -109B -1.64B -11.01B -4.27B -53.24B -4.28B -4.19B -183B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | ₩139,000.00 | +1.68% | 193,800 |
| 26-07-01 | ₩136,700.00 | +3.64% | 77,243 |
| 26-06-30 | ₩131,900.00 | -4.35% | 126,462 |
| 26-06-29 | ₩137,900.00 | +9.10% | 182,220 |
| 26-06-26 | ₩126,400.00 | +1.28% | 179,824 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A271560 Stock
Select your edition
All financial news and data tailored to specific country editions
